financetom
Forex World Market Business Cryptocurrency Commodities MAP
financetom
Business
financetom
/
Business
/
Bristol-Myers Gets EMA Validation For Opdivo Combination Application to Treat Liver cancer
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Bristol-Myers Gets EMA Validation For Opdivo Combination Application to Treat Liver cancer
Jul 19, 2024 8:36 AM

11:17 AM EDT, 07/19/2024 (MT Newswires) -- Bristol-Myers Squibb ( BMY ) said Friday that the European Medicines Agency has validated its type 2 variation application for Opdivo plus Yervoy as a potential first-line treatment for adult patients with unresectable or advanced hepatocellular carcinoma.

The application was based on results from a late-stage trial showing improved survival with the combination compared with lenvatinib or sorafenib, the drugmaker said. Hepatocellular carcinoma is the most common type of primary liver cancer.

The application validation confirms the submission is complete and begins the EMA's centralized procedure review, the firm said.

Price: 41.67, Change: -0.72, Percent Change: -1.70

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: Amazon's Alexa+ Reaches Over 1 Million Users
Market Chatter: Amazon's Alexa+ Reaches Over 1 Million Users
Jun 23, 2025
02:29 PM EDT, 06/23/2025 (MT Newswires) -- Amazon's ( AMZN ) upgraded digital assistant, Alexa+, has reached over a million users, TechCrunch reported Monday, citing the company. Alexa+, which is not yet publicly available, was first unveiled in February and had more than 100,000 users as of May, the report said, citing Amazon ( AMZN ) Chief Executive Andy Jassy....
 Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
 Low start dose of Amgen experimental weight-loss drug limits side effects
Low start dose of Amgen experimental weight-loss drug limits side effects
Jun 23, 2025
June 23 (Reuters) - People started on a low dose of Amgen's ( AMGN ) long-acting experimental obesity drug MariTide lost as much weight as those given high doses but with milder side effects, according to full results of a mid-stage trial presented at a medical meeting on Monday. As a result, Amgen ( AMGN ) said its recently launched...
 Market Chatter: JBS NV Plans $3.5 Billion Debt Offering
Market Chatter: JBS NV Plans $3.5 Billion Debt Offering
Jun 23, 2025
02:30 PM EDT, 06/23/2025 (MT Newswires) -- JBS NV ( JBS ) is planning a $3.5 billion bond sale to extend debt maturities, Bloomberg reported, citing a person familiar with the matter. The Brazilian meat producer is mulling a debt offering with due dates of 10, 30, and 40 years, the person told Bloomberg. The debt offering comes as borrowers...
About
Terms and Conditions Privacy policy Cookie Settings Contact Us
Services
Login register
financetom Market Personal Finance Business Economy Cryptocurrency MAP
Links
zpostcode Recruit weather mreligion Yellowpages sport constellation shopping name game directory literature Word tour furnish Lottery tftnews lyrics News digital car dir Edu Finance
Copyright 2023-2026 - www.financetom.com All Rights Reserved